瑞济生物 (835940.OC)

+ 收藏

财务摘要(报告期)(瑞济生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.220.380.170.350.15
 每股收益 - 稀释(元) 0.220.380.170.35-
 每股收益 - 期末股本摊薄(元) 0.220.380.170.350.15
 每股净资产BPS(元) 2.372.141.941.761.56
 每股经营活动产生的现金流量净额(元) 0.220.370.110.460.15
 每股营业收入(元) 0.560.960.410.910.41
关键比率:
 净资产收益率 - 摊薄(%) 9.4517.738.9519.889.48
 净资产收益率 - 加权(%) 9.9219.469.3722.089.95
 净资产收益率 - 平均(%) 9.9219.469.3722.089.95
 净资产收益率 - 扣除(%) 8.8817.278.4022.3310.78
 总资产净利率 - 平均(%) 9.3818.078.7620.229.17
 总资产报酬率ROA(%) 10.0919.149.5921.559.72
 投入资本回报率ROIC(%) 9.1617.938.9921.049.45
 销售毛利率(%) 87.5486.9587.3085.6985.04
 销售净利率(%) 39.8739.8142.5538.5836.01
 资产负债率(%) 4.536.475.057.926.65
 资产周转率(倍) 0.240.450.210.520.25
 销售商品提供劳务收到的现金/营业收入(%) 107.04100.54102.20102.91103.32
 营业利润同比增长率(%) 30.809.8018.2538.78-19.48
 营业收入同比增长率(%) 37.785.06-0.8417.51-7.76
 利润总额同比增长率(%) 31.1010.8619.7946.36-16.22
 归属母公司股东的净利润同比增长率(%) 29.138.4017.1544.71-24.53
 扣非后归属母公司股东的净利润同比增长率(%) 29.29-6.00-3.3763.95-11.75
 总资产同比增长率(%) 21.5719.6722.0023.2916.08
 总负债同比增长率(%) 9.24-2.24-7.377.9450.73
 净资产同比增长率(%) 22.2321.5524.0924.8214.21
利润表摘要:
 营业总收入(元) 26,039,563.2644,301,536.0918,898,723.7742,169,759.5119,059,375.49
 营业总成本(元) 14,795,495.5724,397,404.5010,108,010.7621,581,874.0010,326,960.76
 营业收入(元) 26,039,563.2644,301,536.0918,898,723.7742,169,759.5119,059,375.49
 营业利润(元) 11,964,899.4120,190,147.819,147,660.0418,387,347.077,735,672.43
 利润总额(元) 11,964,899.4220,069,148.279,126,225.6518,102,933.967,618,685.78
 净利润(元) 10,382,901.7917,634,605.938,040,614.7616,268,229.336,863,722.02
 归属母公司股东的净利润(元) 10,382,901.7917,634,605.938,040,614.7616,268,229.336,863,722.02
 非经常性损益(元) 625,455.83462,662.86493,682.87-1,999,296.43-946,669.61
 归属母公司股东的净利润扣除非经常性损益(元) 9,757,445.9617,171,943.077,546,931.8918,267,525.767,810,391.63
资产负债表摘要:
 流动资产(元) 54,329,423.3954,369,821.9573,149,856.2268,821,732.9657,280,530.47
 固定资产(元) 15,816,691.4817,633,237.8818,243,460.6317,117,980.1717,580,715.86
 资产总计(元) 115,058,853.73106,337,601.5894,640,491.7688,860,836.5877,575,343.92
 流动负债(元) 4,228,212.705,877,427.103,761,873.216,010,397.554,116,976.96
 非流动负债(元) 988,600.921,001,036.161,013,471.401,025,906.641,038,341.88
 负债合计(元) 5,216,813.626,878,463.264,775,344.617,036,304.195,155,318.84
 股东权益(元) 109,842,040.1199,459,138.3289,865,147.1581,824,532.3972,420,025.08
 归属母公司股东的权益(元) 109,842,040.1199,459,138.3289,865,147.1581,824,532.3972,420,025.08
 资本公积(元) 2,290,721.022,290,721.022,290,721.022,290,721.022,290,721.02
 盈余公积(元) 6,176,471.376,176,471.375,217,072.264,413,010.782,786,187.85
 未分配利润(元) 54,999,847.7244,616,945.9335,982,353.8728,745,800.5920,968,116.21
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 27,871,761.4044,538,659.4019,315,066.5043,398,920.4719,691,723.80
 经营活动产生的现金净流量(元) 9,973,091.3217,207,029.144,918,954.5721,522,151.677,163,951.65
 购建固定无形长期资产支付的现金(元) 289,819.962,914,844.082,414,956.001,072,690.00390,572.00
 投资活动产生的现金净流量(元) 700,180.04-43,985,344.08-2,711,956.00-1,071,760.00-390,542.00
 现金及现金等价物净增加(元) 10,673,271.36-26,778,314.942,206,998.5720,450,391.676,773,409.65
 期末现金及现金等价物余额(元) 39,499,014.6428,825,743.2857,811,056.7955,604,058.2241,927,076.20
 折旧与摊销(元) 2,171,188.512,219,642.741,055,454.071,980,194.56981,066.89
公告日期 2024-08-282024-04-262023-08-282023-04-242022-08-26
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院